October 2024

home / publications / evidence-based-oncology / october
Orange City ribbon-cutting | Image credit: FCS press release

Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology

Mary Caffrey
October 25th 2024
ArticleCOVER FEATURE
MinnOncology logo | Image: Minnesota Oncology

The Daily Balancing Act of Value-Based Cancer Care

Laura Joszt, MA
October 14th 2024
ArticleIVBM COVERAGE
Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape

Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape

Rose McNulty
October 14th 2024
ArticleIVBM COVERAGE
TennOnc logo | Image: Tennessee Oncology

Putting a Spotlight on Innovation, Collaboration in Specialty Value-Based Care

Brooke McCormick
October 14th 2024
ArticleIVBM COVERAGE
Medicinal cannabis | image: NJ.gov

Navigating the Complexities of Cancer Care: Cannabis and Cost Considerations

Laura Joszt, MA
October 14th 2024
ArticleIVBM COVERAGE
Emory Winship Cancer Institute | Image: Emory

In Cancer Care, Innovation Comes at a Cost

Rose McNulty
October 14th 2024
ArticleIVBM COVERAGE
Thomas Jefferson | Image: Thomas Jefferson University

Miles Matter: The Geographic Disparity That Impacts Access to CAR T Therapy

Ryan Flinn
October 13th 2024
ArticleHEALTH EQUITY
Image credit: Reese/peopleimages.com | stock.adobe.com

In Wake of Express Scripts Suit, FTC Takes On 3 Largest PBMs

Skylar Jeremias
October 13th 2024
Article
Doing Things Differently: Wilfong Moves to Thyme Care

Doing Things Differently: Wilfong Moves to Thyme Care

Mary Caffrey
October 12th 2024
Article

Lalan Wilfong, MD, a 20-year medical oncologist with Texas Oncology, is senior vice president, value-based care, Thyme Care.

Thyme Care logo | Image : Thyme Care

Beyond Navigation: Thyme Care Ready for Heavy Lifts to Make Value-Based Care Work

Mary Caffrey
October 12th 2024
Article
Oncology models | Image credit: Navista

Tangle of Tech: How Community Oncology Practices Can Successfully Navigate the Health Technology Landscape

Nini Wu, MD, MBA;Anish Arora
October 11th 2024
ArticleCOVER FEATURE
Patient Navigation | Image credit: CDC

Setting the Course for Comprehensive Care Navigation in Oncology

Vishnukamal Golla, MD, MPH;Allan Zuckoff, PhD;Lucy MacPhail, PhD;John Tam, MD;Chevon Rariy, MD
October 11th 2024
ArticleCOVER FEATURE
FDA | Image Credit: © ra2studio - stock.adobe.com

FDA Approves Isatuximab With VRd as First-Line Option for Transplant-Ineligible Multiple Myeloma

Christina Mattina
September 20th 2024
Article

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot receive an autologous stem cell transplant to treat their newly diagnosed multiple myeloma.

Acute myeloid leukemia | Image: St Jude Children's Research Center

Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes

Kyle Munz
September 19th 2024
ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine session at Ohio State University. This article will appear in the October issue of Evidence-Based Oncology.

Cancer health care concept-wladimir1804-stock.adobe.com

From Policy to Practice: NCCN Summit Explores Equity in the Cancer Workforce

Giuliana Grossi
September 13th 2024
ArticleHEALTH EQUITY

The National Comprehensive Cancer Network Policy Summit emphasized the importance of integrating diversity, equity, and inclusion into the oncology workforce to improve cancer care outcomes and address disparities while navigating legal and societal challenges.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo